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Visual Abstract
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER) localized pro-
tein that regulates ER homeostasis and unfolded protein response (UPR). The biology of endogenous MANF in
the mammalian brain is unknown and therefore we studied the brain phenotype of MANF-deficient female and
male mice at different ages focusing on the midbrain dopamine system and cortical neurons. We show that a
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lack of MANF from the brain led to the chronic activation of UPR by upregulation of the endoribonuclease ac-
tivity of the inositol-requiring enzyme 1a (IRE1a) pathway. Furthermore, in the aged MANF-deficient mouse
brain in addition the protein kinase-like ER kinase (PERK) and activating transcription factor 6 (ATF6) branches
of the UPR pathways were activated. Neuronal loss in neurodegenerative diseases has been associated with
chronic ER stress. In our mouse model, increased UPR activation did not lead to neuronal cell loss in the sub-
stantia nigra (SN), decrease of striatal dopamine or behavioral changes of MANF-deficient mice. However,
cortical neurons lacking MANF were more vulnerable to chemical induction of additional ER stress in vitro. We
conclude that embryonic neuronal deletion of MANF does not cause the loss of midbrain dopamine neurons in
mice. However, endogenous MANF is needed for maintenance of neuronal ER homeostasis both in vivo and in
vitro.
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Introduction
Mesencephalic astrocyte-derived neurotrophic factor
(MANF) is a small, endoplasmic reticulum (ER) localized
protein with survival-promoting effects and neuroprotec-
tive properties (Petrova et al., 2003; Voutilainen et al.,
2009). Importantly, MANF has been associated with ER
function as its expression is increased in response to sev-
eral ER stress inducers and it is secreted by ER calcium
depletion (Apostolou et al., 2008; Glembotski et al., 2012).
ER stress is a phenomenon caused by high levels of
misfolded proteins or protein aggregates. To alleviate ER
stress, cells activate the unfolded protein response (UPR)
involving distinct pathways initiated by three ER transmem-
brane stress receptors: inositol-requiring enzyme 1a (IRE1a),
double-stranded RNA-activated protein kinase-like ER
kinase (PERK), and activating transcription factor 6
(ATF6; Walter and Ron, 2011). These pathways enhance
the degradation of misfolded proteins, the protein-fold-
ing capacity, and attenuate protein translation. If the
UPR fails to restore homeostasis, sustained ER stress
may trigger cell death. In fact, upregulation of UPR
genes has been found in the postmortem brains of
Parkinson’s disease patients and chronic ER stress is
speculated to be a contributor to neurodegenerative dis-
eases (Hoozemans et al., 2007; Hetz and Saxena, 2017;
Lindholm et al., 2017). However, we lack critical studies
that show the causative role of chronic ER stress and
neurodegeneration.
MANF and its paralogue, cerebral dopamine neurotro-
phic factor (CDNF; Lindholm et al., 2007), are structurally
characterized by two domains: the amino-terminal domain
is predicted to bind lipids and the carboxy-terminal domain
contains an ER-retention signal and is important for the
anti-apoptotic activity of MANF (Parkash et al., 2009;
Hellman et al., 2011; Mätlik et al., 2015). The Manf gene
promoter carries ER stress response elements I and II,
which are recognized by UPR transcription factors AFT6
and spliced X-box binding protein 1 (sXBP1), thus regulat-
ing Manf mRNA expression (Oh-Hashi et al., 2013; Wang
et al., 2018). Fruit flies express a single CDNF/MANF ho-
mologous gene, DmManf, which was also shown to geneti-
cally interact with Xbp1 (Lindström et al., 2016). MANF
interacts with an ER chaperone glucose-regulated protein
78 (GRP78; Glembotski et al., 2012) and recent data show
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Significance Statement
Exogenous mesencephalic astrocyte-derived neurotrophic factor (MANF) is neuroprotective in animal mod-
els of Parkinson’s disease and stroke, but the function of endogenous MANF in neurons is still elusive. This
is the first study on the role of endogenous MANF in the adult mouse brain with focus on the midbrain dopa-
mine system. We discovered chronic unfolded protein response (UPR) in the brains of mice lacking MANF.
Despite activation of all three UPR pathways, we did not observe degeneration of dopamine neurons, which
contrasts to the previously reported detrimental effect of chronic UPR in pancreatic b cells lacking MANF.
Our findings highlight the complexity of the UPR and reveal that the terminal consequences of chronic UPR
differ in cell types and context.
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that it is the C-terminal domain of MANF that binds to the
nucleotide-binding domain of GRP78, contributing to pro-
tein-folding homeostasis as a nucleotide exchange inhibi-
tor (Yan et al., 2019).
Inactivation of theManf gene in fruit flies causes defects
in the formation of dopaminergic axonal bundles and de-
creased dopamine levels (Palgi et al., 2009). However,
knock-down of neuronal DmManf does not affect the do-
pamine system in adult flies (Stratoulias and Heino, 2015).
In zebrafish, knock-down of Manf results in a decreased
number of dopamine neurons without phenotypic defects
(Chen et al., 2012). In nematodes, a mutation in the Manf
homologue was suggested to result in the gradual degen-
eration of dopamine neurons (Richman et al., 2018), but a
recent study implicated that MANF-depleted nematodes
do not after all display any dopamine phenotype (Hartman
et al., 2019). We have shown that conventional MANF
knock-out (KO) mice and pancreas-specific conditional
KO mice develop insulin-dependent diabetes due to pro-
longed ER stress in pancreatic b cells, leading to loss of
the b cell mass and premature death (Lindahl et al., 2014;
Danilova et al., 2019a). In MANF KO mice, it was also
demonstrated that MANF regulates cortical development
and migration of neuronal progenitor cells (Tseng et al.,
2017). Despite the suggested role of increased UPR acti-
vation behind impaired cortical development, the role of
MANF in the regulation of UPR in neurons in vivo has re-
mained unsolved. Whereas exogenous MANF has dem-
onstrated protection of dopamine neurons in animal
models of Parkinson’s disease (Voutilainen et al., 2009;
Liu et al., 2018), the function of endogenous MANF in the
dopamine neuron maintenance in mice is not known.
To study the role of endogenous MANF in midbrain do-
pamine neurons and in cortical neurons, we analyzed the
brains of conventional and conditional MANF KO mice
with the deletion of Manf from the neural lineage of the
cells in the CNS. In this study, we aimed to characterize
the survival and function of the midbrain dopamine sys-
tem in conditional MANF KO mice and to examine the
effect of MANF absence on ER stress and its consequen-
ces for the survival of neurons.
Materials and Methods
Animals
Mice were housed in an individually ventilated cage
system (Mouse IVC Green Line, Tecniplast) in a specific
pathogen-free facility with a 12/12 h light/dark cycle
(lights on 6 A.M. to 6 P.M.) with access to food pellets
(Harlan Teklad Global Diet) and water ad libitum. Cage en-
richment was provided by bedding (aspen chips 5 5 
1 mm, 4HP, Tapvei), nesting material (aspen strips,
PM90L, Tapvei) and an aspen brick (100 20 20 mm,
Tapvei). Development of KO mice used in the study
have been previously described (Lindahl et al., 2014).
Shortly, Manf-/- mice were generated from an embry-
onic stem cell clone MANF_D06 (EPD0162_3_D06;
C57Bl/6N-Manftm1a(KOMP)Wtsi). The clone included a
b -galactosidase reporter cassette, which had a strong
splice acceptor site between exon 2 and 3 and splicing
from exon 2 to reporter cassette caused a null mutation.
Manffl/fl mice were produced by crossing Manf1/- with
transgenic CAG-Flp mice following removal the b -ga-
lactosidase reporter cassette. Crossing of Manffl/fl mice
with transgenic Cre mice caused removal of exon three
and splicing from exon 2 to exon 4. This resulted in a
frameshift and premature stop codon and therefore
with truncated Manf mRNA. Manf1/1 and Manf-/- mice
were maintained in an outbred ICR background and
bred from heterozygous Manf1/- parents. Manffl/fl mice
and Manffl/fl::NestinCre/1 were in a mixed ICR/C57BL/
6JRccHsd genetic background, and NestinCre/1 mice were
only in the C57BL/6JRccHsd background (Envigo). Mice
used for most of the behavioral studies were bred over
eight generations in the C57BL/6JRccHsd background.
Only male mice were used in the behavioral testing, where-
as in the other experiments the use of either female or male
mice has been informed in the figure legends. Data groups
of embryonic and postnatal (P1 and P14) mice include
both genders. For sample collection, brains were dissected
from euthanized mice, snap frozen in liquid nitrogen and
stored at 75°C. For immunohistochemistry, mice were
heavily anaesthetized and perfused transcardially with PBS
first and then with 4% paraformaldehyde (PFA) in PBS. The
experiments with mice were approved by the National
Animal Experiment Board in Finland, and the project li-
cense numbers were ESAVI/10564/04.10.07/2014 and
ESAVI/11865/04.10.07/2017.
Blood glucose level measurements and glucose
tolerance test
Blood glucose levels were measured in random-fed ani-
mals with a glucometer (Accu-Chek Aviva Glucometer,
Roche Diagnostics). For the glucose tolerance test, mice
were starved for 16 h in their home cages. After measure-
ment of basal blood glucose levels, D-glucose (2 g/kg)
was injected intraperitoneally, and blood glucose levels
were measured at different time points during 2 h.
Immunohistochemistry
PFA-fixed and paraffin-embedded brains were cut into
5-mm-thick sections. After paraffin removal, the sections
were boiled in 10mM citrate buffer (pH 6.0) for 10min to re-
trieve antigens. The endogenous peroxidase activity was
inactivated by incubation with 0.6% hydrogen peroxide in
Tris-buffered saline, pH 7.4 (TBS). Sections were washed
in TBS with 0.1% Tween 20 (TBS-T) and blocked with
1.5% goat/donkey serum in TBS-T. Sections were incu-
bated with a primary antibody overnight at 14°C. Primary
antibodies used were anti-MANF (1:1000, 310–100,
Icosagen, RRID:AB_11135308), anti-tyrosine hydroxylase
(TH; 1:1000, MAB318, Millipore, RRID:AB_2201528), anti-
DAT (1:1000, MAB369, Millipore, RRID:AB_2190413), and
anti-neuronal nuclear protein (anti-NeuN) NeuN (1:500,
MAB377, Millipore, RRID:AB_2298772). After incubation
with biotinylated secondary antibodies, sections were de-
tected with Vector diaminobenzidine peroxidase substrate
kit (Vector Laboratories). Secondary antibody used was
horse anti-mouse (1:200, BA-2000, Vector Laboratories).
Research Article: New Research 3 of 20
January/February 2020, 7(1) ENEURO.0477-19.2019 eNeuro.org
In immunofluorescence staining, blocking solution was
added for 1 h after antigen retrieval and the primary antibody
was kept overnight. The primary antibodies used were
anti-TH (1:500, MAB318, Millipore, RRID:AB_2201528) and
anti-GRP78 (1:500, ab21685, Abcam, RRDI:AB_2119834).
Sections were incubated with fluorescent-labeled second-
ary antibodies, and after a 1-h incubation, they were washed
three times with TBS-T and mounted with a medium
containing 496-diamidino-2-phenylindole (DAPI; H-1200,
Vectashield, Vector Laboratories).
Counting of dopamine neurons
To count the relative number of dopamine neurons in
the substantia nigra (SN), four nigral sections within an
interval of 100–120 mm were selected for the staining.
TH-stained sections of the SN were scanned with an au-
tomated scanner (3DHistech). An area of the SN pars
compacta (SNpc) from each hemisphere was defined
separately based on morphologic landmarks and an esti-
mation of dopamine neuron number was performed with
a MATLAB algorithm based on intensity from TH-immuno-
reactive sections (Penttinen et al., 2016). In the paper of
Penttinen et al. (2016), the method was validated by com-
paring stereological counting with this newmethod and an-
alyzing dopamine neurons in different PD models. Counts
were performed bilaterally and results are presented as rel-
ative change in the cell number per stained section.
Optical density measurement
Images of TH-immunostained and DAT-immunostained
striatal sections were scanned with a 3DHistech scanner.
Striata were defined from pictures, and optical density
was measured with an Image-Pro Analyzer 7.0. The opti-
cal density of a cortical region above the striatum was
subtracted as a background signal. Six sections per ani-
mal were used for the analysis. The results of integrated
optical density are shown as an average and percentage
of the control mice.
Measurement of dopamine and serotonin levels
The neurotransmitter levels from dissected striata
were measured by high-performance liquid chromatog-
raphy (HPLC) as previously described (Airavaara et al.,
2006). Tissue samples were homogenized in a solution
containing 0.2 M HClO4 and antioxidants following cen-
trifugation at 14,000 rpm for 35min. Supernatant was
further filtered with Vivaspin columns by centrifugation
at 9000 rpm for 35min. From striatal tissues samples,
concentrations of dopamine, 3,4-dihydroxyphenylacetic
acid (DOPAC), homovanillic acid (HVA), serotonin, and 5-
hydroxyindoleacetic acid were analyzed with a HPLC in-
cluding an electrochemical detector.
Real-time quantitative PCR (qPCR)
Total RNA was isolated by phenol–chloroform extrac-
tion with TRI Reagent (Molecular Research Center).
Briefly, TRI reagent (Invitrogen, Thermo Fisher Scientific)
was added to samples, followed by mechanical disruption
by grinding with a pestle or by pulling through a needle by
a syringe. Chloroform (1:4) was added to the samples,
which were centrifuged at 13,000 rpm for 15min. The
aqueous phase was collected and isopropanol (1:1)
added. For small samples, glycogen (Thermo Fisher
Scientific) was added to visualize the pellet. After incuba-
tion, the samples were centrifuged at 13,000 rpm for
15min, followed by washing of the pellet twice with 75%
ethanol. The pellet was air-dried and dissolved in water.
RNA concentration was measured by NanoDrop and equal
amounts of RNA were used for synthesizing complemen-
tary DNA. RNA quality was assessed by measuring UV ab-
sorbances of the RNA samples. Reverse transcription
reaction was catalyzed by RevertAid Premium Reverse
Transcriptase (Thermo Fisher Scientific) or Maxima H
Minus Reverse Transcriptase (Thermo Fisher Scientific) in
the presence of 10 mM NTP mix (Fermentas UAB) and
oligo-d(T) (Metabion International). qPCR was performed
with Lightcycler 480 SYBR Green I Master mix (Roche
Diagnostics) using Lightcycler 480 Real-Time PCR System
(Roche). The mRNA levels of the target gene were normal-
ized to levels of b -actin as a reference gene, and quantifi-
cation was performed by a standard curve method. Primer
sequences were designed to span exon-exon junctions.
Primer sequences were: Atf4 F 59-ATG GCC GGC TAT
GGA TGA T-39, Atf4 R 59-CGA AGT CAA ACT CTT TCA
GAT CCA TT-39, Atf6a F 59-GGA CGA GGT GGT GTC
AGA G-39, Atf6a R 59-GAC AGC TCT TCG CTT TGG AC-
39, Bcl10 F 59-AAA CTG GAG CAC CTC AAA GG-39, Bcl10
R 59-TCT CAT CGG AAT TGC ACC TA-39, Bdnf F 59-TAC
CTG GAT GCC GCA AAC AT-39, Bdnf R 59-GCT GTG ACC
CAC TCG CTA AT-39, Cdnf F 59-GCT CAG ATG CCA AAG
GAA AA-39, Cdnf R 59-TAG GAT CTT GGT GGC TGC AT-
39, Chop F 59-CCA ACA GAG GTC ACA CGC AC-39, Chop
R 59-TGA CTG GAA TCT GGA GAG CGA-39, Dat F 59-AAC
CTG TAC TGG CGG CTA TG-39, Dat R 59-GCT GAC CAC
GAC CAC ATA CA-39, Grp78 F 59-ACC CTT ACT CGG
GCC AAA TT-39, Grp78 R 59-AGA GCG GAA CAG GTC
CAT GT-39, Manf F 59-GAC AGC CAG ATC TGT GAA CTA
AAA-39, Manf R 59-TTT CAC CCG GAG CTT CTT C-39,
sXbp1 F 59-GAG TCC GCA GCA GGT G-39, sXbp1 R 59-
GTG TCA GAG TCC ATG GGA-39, Th F 59-CCC AAG GGC
TTC AGA AGA G-39, Th R 59-GGG CAT CCT CGA TGA
GAC T-39, tXbp1 F 59-CAC CTT CTT GCC TGC TGG AC-
39, tXbp1 R 59-GGG AGC CCT CAT ATC CAC AGT-39,
Txnip F 59-TCA AGG GCC CCT GGG AAC ATC-39, Txnip R
59-GAC ACT GGT GCC ATT AAG TCA G-39.
Western blotting
Samples were homogenized in lysis buffer composed
of 10 mM Tris-HCl (pH 8.0), 300 mM NaCl, 4 mM EDTA,
0.2% Triton X-100, and a protease inhibitor cocktail
(cOmplete, Roche, 04693159001). Also, a phosphatase
inhibitor (PhosStop, Roche, 04906837001) or 1 mM so-
dium orthovanadate was added to inhibit phosphatase
activity. Homogenates were incubated on ice for 1 h,
followed by centrifugation at 13,000 rpm for 20min. The
supernatant was collected, and protein concentrations
were measured with DC protein assay (Bio-Rad Labor-
atories) according to the manufacturer’s instructions. To
equalize protein concentrations, samples were diluted in
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lysis buffer and then mixed with Laemmli buffer containing
2% 2-mercaptoethanol. Samples were heated at 195°C
for 5min. For DAT detection, striatal samples were homog-
enized in a 10 mM HEPES (pH 7.2), buffer containing 0.3 M
sucrose, 1 mM EDTA and protease inhibitors. The samples
were incubated with Laemmli buffer at 137°C for 50min
and run on self-made or pre-cast gels (Bio-Rad). Proteins
were transferred onto nitrocellulose membranes, which
were blocked with 5% milk or 5% BSA in TBS-T for 1 h
and incubated with primary antibody solution overnight.
The primary antibodies used were: anti-GRP78 (1:1000,
sc-1051, Santa Cruz Biotechnology, RRDI:AB_2119994), anti-
eIF2a (1:1000, 9722, Cell Signaling, RRID:AB_2230924), anti-
peIF2a (1:1000, 9721, Cell Signaling, RRID:AB_330951),
anti-GAPDH (1:3000, MAB374, Millipore, RRID:AB_2107445),
anti-TH (1:1000, MAB318, Millipore, RRID:AB_2201528), anti-
DAT (1:1000, MAB369, Millipore, RRID:AB_2190413), anti-
p-NF-kB (1:1000, 3033, Cell Signaling, RRID:AB_10859369),
and anti-NF-kB (1:1000, 8242, Cell Signaling, RRID:AB_
331284). Secondary antibody was applied for 1 h and
detected with chemiluminescence ECL Blotting Substrate
(Pierce, Thermo Fisher Scientific). The secondary antibodies
used were: goat anti-mouse (1:3000, P0447, Dako), donkey
anti-rabbit (1:3000, NA9340V, GE Healthcare), goat anti-rat
(1:1000), and rabbit anti-goat (1:1500, P0449, Dako). Protein
bands were quantified with ImageJ software. Protein
amounts were normalized to GAPDH.
Primary dopamine cell cultures
To culture midbrain dopamine neurons from single em-
bryos, the method of micro-island cultures was used.
Micro-islets were drilled into four-well plates and coated
with poly-ornithine. Midbrain floors were dissected from
E13.5 embryos, collected in Dulbecco’s media and washed
with HBSS. Cells were detached by trypsin treatment at
137°C for 20–30min. To stop the reaction, fetal bovine
serum (FBS) was added and cells were triturated. After the
sedimentation of cells, the supernatant was collected and
the trituration repeated. Cells were centrifuged for 5min at
1000 rpm. The pellet was washed twice with the media and
dissolved in the media. Approximately 2000–3000 cells
were added to each micro-island. Some plates were fixed
on the first day in vitro (DIV1). For other plates, half of the
media was changed at DIV2 and fixed at DIV5. Cells were
fixed with 4% PFA, washed and permeabilized with 0.2%
Triton X-100 in PBS. Samples were blocked with 5% horse
serum10.2% Triton X-100 in PBS and incubated with anti-
TH antibody (1:1000, MAB318) overnight. Specimens were
incubated with secondary antibody (1:400, Alexa Fluor 488
Goat Anti-mouse, Life Technologies, A11029) for 1 h, and
nuclei were stained with DAPI (1:5000) for 10min. Images
frommicro-islands were taken with a Leica fluorescent cam-
era DC300F and TH1 cells were quantified from images
with ImageJ (Rueden et al., 2017). Each data point was an
average of at least twomicro-islands.
Primary cortical cell cultures
Cortex was collected from mouse fetuses at gestational
day 16 (E16) or E17 separately and later genotyped.
Cortical pieces were washed twice with HBSS. Samples
were incubated with 0.5% trypsin for 15min at 137°C,
followed by addition of HBSS1 10% FBS and DNase I.
Centrifuged pellets were washed twice with HBSS1FBS
solution. Neurobasal medium (Invitrogen) supplemented
with B27 (1, Invitrogen), 500 mM glutamine, and primo-
cin was added on top of the pellet and pipetted until tis-
sue pieces were separated. Cells were centrifuged and
washed with media. Dissociated neurons were counted,
and cells were plated on poly-ornithine coated 96-well or
12-well plates at the amount per well of 2.5 104 and
4 105, respectively. Half of the medium was changed
every 2–4d. Cortical neurons cultured on 12-well plates
were treated with 20 mM 5-fluoro-29-deoxyuridine (F0503,
Sigma-Aldrich) and 20 mM uridine (U3750, Sigma-Aldrich)
from DIV2 to DIV5 to reduce the number of glial cells.
Treatments were performed during media change at
DIV9. Neurons cultured on 96-well plates were fixed
with 4% PFA. They were permeabilized with 0.2% Triton
X-100 in PBS for 15min and blocked with 5% horse
serum in 0.2% Triton X-100 in PBS. A primary antibody
(anti-NeuN, 1:500, MAB377, Millipore) was added to the
blocking medium and incubated overnight. After incuba-
tion with a secondary antibody (1:400, Alexa Fluor 488
goat anti-mouse, Life Technologies, A11029) for 1 h, the
nuclei were stained with DAPI. Cultures were imaged with
a CellInsight CX5 instrument (Thermo Fisher Scientific)
and the number of NeuN-positive cells was analyzed
automatically by designed image analysis workflow in
CellProfiler and CellProfiler Analyst programs (Carpenter et
al., 2006; Jones et al., 2009). Neurons grown on 12-well
plates were used for RNA extraction or Western blotting in
the same way as described above.
Multiple static rods
The performance of a mouse on five rods with increas-
ing diameter (rod 1: 27 mm, rod 2: 21 mm, rod 3: 15 mm,
rod 4: 11 mm, rod 5: 8 mm) was measured. At the begin-
ning of a test, a mouse was placed at the end of the round
beam facing away from the supporting platform. The la-
tencies to turn 180°, walk 60 cm, and possible fall off were
measured within a maximum of 2min.
Wire hanger test
A mouse was placed in the middle of the horizontal
hanger grid. The mouse was observed for 1min, and the
latency to fall was measured.
Accelerating rotarod
Mice were trained once on an accelerating rotarod
(from 4 to 40 rpm during 4min). Later on, the same day,
the latency to fall was measured with the 4-min cutoff
time.
Open-field activity
Mice were placed in the corner of an open-field arena
(30 30 cm, Med Associates). The horizontal activity was
monitored for 30min. For testing amphetamine-induced
locomotor activity, mice were first habituated in the open-
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field arenas for 30min. Mice were then injected with 3mg/
kg D-amphetamine intraperitoneally and placed back in
the same chambers. The horizontal activity was measured
for another 90min.
Barnes maze
A circular elevated platform (diameter 100 cm) con-
tained 20 equally distributed holes (diameter, 5 cm)
around the perimeter. An escape box was placed under
one of the holes. Mice were trained to find the escape box
during training sessions of a maximum of 3min per time.
The trial was ended either when the animal entered the
box or 3min had elapsed; in the latter case the animal
was guided to the box by hand and allowed to enter it.
Training was conducted three times per day (with an
inter-trial interval of at least 1 h) on three consecutive
days. On day 4, for testing of memory in probe trial 1, the
box was removed and mice had 1.5min to navigate to the
right place. For reverse training, the escape box was set
at the opposite side of the maze. Reverse trainings of
3min occurred three times per day on two consecutive
days. The maze was cleaned with water between every
animal. The trials were recorded with video tracking soft-
ware Ethovision XT10 (Noldus). The distance traveled and
the latency to find the escape box were measured during
the training trial; in addition, the time spent in a zone sur-
rounding the target hole was measured in the probe trial.
Statistical analysis
Statistical analysis was performed using either SPSS
Statistics (version 24, IBM) or GraphPad Prism (version
7.04, GraphPad Software). Student’s t test was used when
comparing two groups when data were normally distrib-
uted. If data were not normally distributed or Levene’s test
for equality of variances showed unequal variances, the
Mann–Whitney U test was used to compare two groups. If
only part of the large dataset was not normally distributed,
the nonparametric Mann–Whitney U test was still used to
make consistent analysis. Data with three groups and one
factor were analyzed with one-way ANOVA, followed by
Tukey’s post hoc test, and if data were not normally distrib-
uted, the nonparametric Kruskal–Wallis test followed by
Mann–WhitneyU test was used. For tests with manymeas-
urements from the same subject, we used two-way
ANOVA for repeated measures. For the data, where thapsi-
gargin was used as a treatment, two-way ANOVA was
used to analyze genotype–treatment interaction, and it was
followed by Tukey’s post hoc test. The behavioral tests
and analysis were performed blinded. All results are pre-
sented as mean 6 SEM and regarded as significant when
p, 0.05. The statistical test used are listed in Table 1 and
Extended Data Table 1-1, but significant exact p values
from Mann–Whitney U test and Tukey’s post hoc test are
presented in the figures due to clarity.
Results
Conditional deletion of MANF in the nervous system
Conditional MANF KO mice were produced by deleting
an exon three of the Manf gene by crossing the floxed
mice (Manffl/fl) with transgenic NestinCre/1 mice. Cre re-
combinase expressed under the Nestin promoter in
NestinCre/1 transgenic mice is induced predominantly in
the CNS (Tronche et al., 1999). Later, it was reported that
in the NestinCre/1 line used, recombination is observed in
neural stem cells and neural progenitor cells from E12.5
but with incomplete efficiency (Dubois et al., 2006). Since
MANF is mainly expressed in neurons in the adult mouse
brain (Lindholm et al., 2008; Tseng et al., 2017; Danilova
et al., 2019a,b), this recombination is expected to remove
most of the MANF in the brain. Consequently, qPCR anal-
ysis showed barely detectable levels of Manf mRNA ana-
lyzed from the brain lysates from different brain areas of
Manffl/fl::NestinCre/1mice compared with littermateManffl/fl
mice (Fig. 1A; Table 1). Brain regions analyzed were se-
lected based on their normally high MANF expression
(Lindholm et al., 2008). Importantly, Manf mRNA levels
were similar in the cortex between control Manffl/fl and
NestinCre/1 mice, and reduced as expected in Manffl/fl::
NestinCre/1 mice (Fig. 1B; Table 1). This result indicates
the comparable levels of Manf mRNA in Manffl/fl and
NestinCre/1 mice. Consistent with the Manf mRNA levels,
immunoreactivity for MANF with a validated MANF-spe-
cific antibody was detected in the brains of Manffl/fl mice,
but the signal was almost fully lost in Manffl/fl::NestinCre/1
mouse brain counterstained with hematoxylin (Fig. 1C).
The loss of MANF did not affect Cdnf mRNA expression
levels in the Manffl/fl::NestinCre/1 brain areas (Fig. 1D;
Table 1) or the BdnfmRNA levels measured from the cort-
ical and hippocampal tissue (Fig. 1E; Table 1).
In contrast to global Manf-/- mice in the ICR strain that
die prematurely (Lindahl et al., 2014) and Manf-/- mice in
the C57BL/6 strain that are perinatal lethal (Neves et al.,
2016; Bell et al., 2019), Manffl/fl::NestinCre/1 mice were via-
ble and visibly similar to littermates when followed until the
age of 18months. The body weights ofManffl/fl::NestinCre/1
mice were reduced at four and 16months of age compared
with the Manffl/fl controls but when comparing Manffl/fl::
NestinCre/1mice with NestinCre/1mice, there was no differ-
ence in body weight (Fig. 1F; Table 1). Since conventional
MANF KOmice develop diabetes by the age of sevenweeks
(Lindahl et al., 2014), we followed the blood glucose levels
to rule out the possible development of hyperglycemia. In
line with the previously published data (Lindahl et al., 2014),
blood glucose levels of random-fed Manffl/fl::NestinCre/1
mice stayed similar to Manffl/fl controls until the age of
16months (Fig. 1G; Table 1). The glucose tolerance test
measuring insulin secretion and sensitivity was performed
by injecting glucose followed by measuring the rate of glu-
cose clearance from the blood stream. Both Manffl/fl and
Manffl/fl::NestinCre/1 mice showed similar glucose clearance
over time (Fig. 1H; Table 1).
MANF deficiency causes robust activation of IRE1a
signaling pathway in the brain
Previously it has been shown that loss of MANF in pan-
creatic b cells leads to chronic UPR activation in vivo
(Lindahl et al., 2014). Recently, it was also demonstrated
that ablation of MANF in cartilage results in upregulation
of ER chaperones in vivo (Bell et al., 2019). Therefore, we
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examined the expression of UPR-related genes in the brains
of both conventional Manf-/- and conditional Manffl/fl::
NestinCre/1 KO mice. The studied UPR-related genes were
selected from all three UPR branches in addition to the
major UPR sensor GRP78 (alias BiP), which in normal condi-
tions binds to these ER transmembrane UPR transducers
but dissociates whenmisfolded proteins start to accumulate
in the ER (Lee, 2005).
First, the qPCR analysis performed on cDNA from the
brains of Manf1/1 and Manf-/- mice indicated that the
mRNA levels of all the UPR-related genes from three UPR
pathways, Atf4, Atf6a, C/EBP homologous protein
(Chop), Grp78, sXbp1 (activated by IRE1a endoribonu-
clease activity), and total Xbp1 (tXbp1), were upregulated
in the embryonic E13.5 Manf-/- mice brains and postna-
tally in the brains from newborn and two-week-oldManf-/-
mice (Fig. 2A; Table 1). Next, the UPR induction was ana-
lyzed in the brain tissue of five-week-old Manf-/- mice at
the age of manifestation of high blood glucose levels and
diabetes (Lindahl et al., 2014). The brain regions analyzed
were the cortex, striatum, hippocampus, SN and cerebel-
lum. The Atf6a mRNA levels were not increased in any
brain region analyzed from five-week-old Manf-/- mice
(Fig. 2B; Table 1). However, mRNAs encoding for Chop
and Atf4, which are synthesized and activated despite the
translational initiation block in the PERK pathway, were
both upregulated in the cortex of Manf-/- mice (Fig. 2B;
Table 1). Interestingly, mRNA levels of the spliced form of
a transcription factor XBP1 (sXbp1) were significantly up-
regulated by 6.1- to 11.5-fold in the cortex, striatum, SN,
and cerebellum, indicating the activation of the IRE1a sig-
naling pathway (Fig. 2B; Table 1). In addition to sXbp1,
Table 1. Statistical analysis
Dataset Data structure Type of test Power
Figure 1A Non-normal distribution Mann–Whitney U Significant p values in the figure
Figure 1B Non-normal distribution Kruskal–Wallis, Mann–Whitney U H(2) = 11.33, p = 0.003
Figure 1D,E Non-normal distribution Mann–Whitney U No significance
Figure 1F Normal distribution One-way ANOVA, Tukey’s HSD 4-month-old mice F(2,22) = 20.42, p , 0.001; 12-month-old mice F(2,22) =
6.35, p = 0.007
Figure 1G Normal distribution Two-tailed t test and one-way ANOVA 2-month-old mice t(30) = 0.93, p = 0.360; 16-month-old mice F(2,22) = 0.43,
p = 0.659
Figure 1H Normal distribution Two-way RM ANOVA Genotype  time interaction F(6,54) = 0.88, p = 0.517
Figure 2A–G Non-normal distribution Mann–Whitney U Significant p values presented in the figure
Figure 2H Normal distribution Two-tailed t test Cortex Txnip t(6) = 1.046, p = 0.34; Cortex Bcl10 t(12) = 0.59, p = 0.564; SN
Txnip t(10) = 1.15, p = 0.279; SN Bcl10 t(10) = 0.41, p = 0.688
Figure 3A Normal distribution One-way ANOVA, Tukey’s HSD Atf6a F(2,13) = 0.08, p = 0.924; Atf4 F(2,13) = 0.08, p = 0.927; Chop F(2,13) =
1.19, p = 0.334; Grp78 F(2,13) = 9.70, p = 0.003; sXbp1 F(2,13) = 99.98,
p , 0.001; tXbp1 F(2,13) = 0.032, p = 0.968
Figure 3B Normal distribution One-way ANOVA, Tukey’s HSD Atf6a F(2,11) = 5.88, p = 0.018; Atf4 F(2,11) = 7.13, p = 0.010; Chop F(2,11) =
0.25, p = 0.781; Grp78 F(2,11) = 15.18, p = 0.001; sXbp1 F(2,10) = 134.32,
p , 0.001; tXbp1 F(2,11) = 5.39, p = 0.023
Figure 3C Normal distribution One-way ANOVA Txnip F(2,11) = 1.22, p = 0.331; Bcl10 F(2,11) = 1.13, p = 0.358
Figure 4A Normal distribution Two-tailed t test t(8) = 1.89, p = 0.095
Figure 4C Normal distribution Two-tailed t test TH-fibers t(8) = 0.32, p = 0.760; DAT-fibers t(8) = 0.71, p = 0.499
Figure 4E Non-normal distribution Kruskal–Wallis, Mann–Whitney U DA H(2) = 6.68, p = 0.035, DOPAC H(2) = 6.68, p = 0.541; HVA H(2) = 0.422,
p = 0.810; 5-HT H(2) = 1.618, p = 0.445; 5-HIAA H(2) = 0.23, p = 0.893
Figure 5A Non-normal distribution Kruskal–Wallis, Mann–Whitney U Time to turn on the rod 1 H(2) = 9.60, p , 0.001
Figure 5B Non-normal distribution Kruskal–Wallis H(2) = 3.07, p = 0.216
Figure 5C Normal distribution One-way ANOVA F(2,25) = 2.77, p = 0.082
Figure 5D Normal distribution One-way ANOVA F(2,22) = 1.44, p = 0.259
Figure 5E Normal distribution One-way ANOVA, Tukey’s HSD F(2,25) = 3.99, p = 0.031
Figure 5F Normal distribution One-way ANOVA F(2,19) = 1.94, p = 0.172
Figure 5G Normal distribution Two-way RM ANOVA Genotype  time interaction F(46,529) = 1.10, p = 0.314
Figure 5H Normal distribution Two-way RM ANOVA Genotype  time interaction F(46,460) = 0.65, p = 0.964
Figure 5I Normal distribution Two-way RM ANOVA Trials 1–9 F(16,176) = 0.57, p = 0.905, trials 10–15 F(10,110) = 0.39, p = 0.947
Figure 5J Non-normal distribution Kruskal–Wallis Trial I H(2) = 0.044 p = 0.978, Trial II H(2) = 0.244 p = 0.885
Figure 6A Normal distribution Two-tailed t test t(13) = 1.59, p = 0.137
Figure 6B Normal distribution One-way ANOVA, Tukey’s HSD Atf6a F(2,12) = 3.42, p = 0.067; Atf4 F(2,12) = 7.76 p = 0.007; Chop F(2,12) =
3.72, p = 0.056 ; Grp78 F(2,12) = 13.05, p = 0.001; sXbp1 F(2,12) = 17.85,
p = 0.003; tXbp1 F(2,12) = 19.42, p = 0.002; Bcl10 F(2,14) = 1.84, p =
0.196
Figure 6C Normal distribution Two-way ANOVA, Tukey’s multiple comparison Genotype  treatment interaction F(4,36) = 2.82, p = 0.039
Figure 6D–K Normal distribution Two-way ANOVA, Tukey’s multiple comparison Genotype  treatment interactions: Atf6a F(2,20) = 0.40, p = 0.677; Atf4
F(2,20) = 1.40, p = 0.270; Chop F(2,20) = 0.07, p = 0.934; Grp78 F(2,20) =
0.71, p = 0.504; sXbp1 F(2,18) = 5.73, p = 0.012; tXbp1 F(2,20) = 0.19, p =
0.826; Bcl10 F(2,20) = 1.72, p = 0.203, Txnip F(2,16) = 1.40, p = 0.275
Figure 6M Normal distribution Two-way ANOVA Genotype  treatment interactions: p-NF-kB/NF-kB F(1,14) = 1.698, p =
0.214
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the mRNA levels of Grp78 were significantly increased in
all examined brain areas of five-week-oldManf-/-mice.
As experimentally-induced hyperglycemia and high-fat
diet induced diabetes have been shown to increase ER
stress and UPR activation in rodent brains (Zhao et al.,
2015; Sims-Robinson et al., 2016), we studied the effect
of MANF removal devoid of the hyperglycaemic effect
in the brain tissue of Manffl/fl::NestinCre/1 mice. We
examined UPR-related gene expression in the same
brain regions of two-month-old Manffl/fl::NestinCre/1 mice
and their Manffl/fl littermates. The increase in Xbp1 splic-
ing in Manffl/fl::NestinCre/1 mice varied between brain
regions, there was a 4.7-fold increase in the cortex, 3.7-
fold increase in the striatum, 7.1-fold increase in the
Figure 1. Generation of CNS-specific MANF KO mice. A, Manf mRNA levels in different brain areas of two-month-old Manffl/fl and
Manffl/fl::NestinCre/1 female mice determined by qPCR (n= 4–9). Results are scaled to the average value of the control samples. B,
Manf mRNA levels of 16-month-old Manffl/fl, Manffl/fl::NestinCre/1, and NestinCre/1 male mice (n=5–6). C, Immunoreactivity for en-
dogenous MANF with hematoxylin counterstaining in the brains of Manffl/fl and Manffl/fl::NestinCre/1 mice. Scale bar: 200 mm. D,
Cdnf mRNA levels in different brain areas of two-month-old female mice (n= 4–9). E, Bdnf mRNA levels in the cortex and hippocam-
pus of two-month-old female mice (n=6–8). F, Weights measured from Manffl/fl, Manffl/fl::NestinCre/1, and NestinCre/1 male mice at
the age of four and 16months (n= 6–14). G, Blood glucose levels of Manffl/fl::NestinCre/1 female and male mice and their littermate
controls (n= 3–10). H, Glucose tolerance test performed for 16-month-old Manffl/fl and Manffl/fl::NestinCre/1 female mice (n=5).
Mann–Whitney U test, Student’s t test, one-way and two-way ANOVA followed by Tukey’s post hoc test, or Kruskal–Wallis followed
by Mann–Whitney U test were used for statistical analysis. Data are presented as mean 6 SEM.
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hippocampus, 4.4-fold increase in the SN, and as much
as an 11.2-fold increase in the cerebellum (Fig. 2C; Table
1). In addition, mRNA levels of Grp78 were significantly in-
creased in all brain regions studied. Thus, upregulation of
UPR genes Grp78 and sXbp1 was shared between con-
ventional Manf-/- mice and conditional Manffl/fl::NestinCre/1
mice, confirming that this is a phenotype caused by MANF
deficiency and not diabetes.
Next, we estimated protein levels of two ER stress
markers, GRP78 and phosphorylated eukaryotic transla-
tion initiation factor 2a (p-eIF2a), in the brain homoge-
nates ofManffl/fl andManffl/fl::NestinCre/1 mice. During ER
stress, activation of PERK results in phosphorylation of
eIF2a, leading to global translational repression (Walter
and Ron, 2011). Results showed that the protein levels of
GRP78 were significantly increased in the cortex, striatum
and cerebellum (Fig. 2D,E; Table 1). Furthermore, the
phosphorylation of eIF2a was significantly increased in
the cerebellum, suggesting activation of the PERK path-
way as well (Fig. 2D,F), but the expression of eIF2a was
not increased (Fig. 2D,G). Despite the increase in the
phosphorylation of eIF2a, the mRNA levels of Atf4 were
not upregulated in conditionalManffl/fl::NestinCre/1 brain.
In addition to its endoribonuclease (RNase) activity,
IRE1a has a kinase activity that in ER stress, is responsi-
ble for recruitment of TRAF2 and further activation of the
pro-inflammatory pathway, the nuclear factor k subunit
(NF-kB; Walter and Ron, 2011; Tam et al., 2012).
Recently, it was shown that exogenously added MANF re-
duces activation NF-kB pathway and downregulates B-
cell lymphoma 10 (BCL10) mRNA expression in cytokine-
treated human pancreatic islets in vitro (Hakonen et al.,
2018). BCL10 is a pro-apoptotic protein and an upstream
regulator of the NF-kB pathway (Ruland et al., 2001).
Silencing of MANF in a cytokine-treated human b cell line
results in an increase of BCL10 mRNA expression
(Hakonen et al., 2018). Therefore, we also analyzed the
mRNA levels of Bcl10 in Manffl/fl::NestinCre/1 mice. However,
we did not see changes in the expression levels of Bcl10
mRNA in the cortex and SN of Manffl/fl::NestinCre/1 mice
compared withManffl/flmice (Fig. 2H; Table 1).
Activation of IRE1a RNase activity has been shown to
induce expression of thioredoxin interacting protein
(Txnip) by degradation of Txnip mRNA destabilizing
miRNA-17 (Lerner et al., 2012). TXNIP expression has
been associated with guiding b cells to terminal UPR fol-
lowing IRE1a hyperphosphorylation, oligomerization and
increased inflammatory signaling (Morita et al., 2017).
Therefore, we measured the mRNA levels of Txnip, but re-
sults showed no changes in the levels of Txnip mRNA
expression in the cortex or SN of two-month-oldManffl/fl::
NestinCre/1mice (Fig. 2H; Table 1).
All three UPR pathways are activated in MANF-
deficient mouse brain during aging
To examine whether UPR activation continues during
aging, we analyzed UPR genes in the cortex and SN of
16-month-old Manffl/fl::NestinCre/1 mice. Similarly to the
two-month-old mice, both Grp78 and sXbp1mRNA levels
were almost identically upregulated in the cortex of 16-
month-old mice (Fig. 3A; Table 1). This time, also
NestinCre/1mice were included as another control, but the
results showed similar mRNA levels between Manffl/fl and
NestinCre/1 mice. Interestingly, in the SN of 16-month-old
Manffl/fl::NestinCre/1 mice, expression of Atf6a and Atf4
was also upregulated when compared with control mice, in-
dicating activation of the ATF6 and PERK pathways in addi-
tion to the IRE1a pathway (Fig. 3B; Table 1). In comparison
with the situation in younger mice, when only the IRE1a
pathway was activated, 16-month-old Manffl/fl::NestinCre/1
mice had all three UPR pathways activated in the SN.
We also analyzed mRNA levels of both Bcl10 and Txnip
in the SN of 16-month-old Manffl/fl, NestinCre/1 and Manffl/
fl::NestinCre/1 mice. These markers, however, had still not
changed (Fig. 3C; Table 1). Finally, GRP78 expression was
confirmed to localize to TH-positive dopamine neurons in
the SN of Manffl/fl and Manffl/fl::NestinCre/1 mice by immu-
nohistochemical costaining of GRP78 and TH (Fig. 3D).
MANF deficiency does not affect the number of
midbrain dopamine neurons during ageing
Previous studies have implied that chronic UPR activa-
tion has an impact on neuronal survival in the brain as ER
stress is associated with neurodegeneration (Hetz and
Saxena, 2017; Lindholm et al., 2017). Thus, the chronic
ER stress found in the brains of Manffl/fl::NestinCre/1 mice
would indicate decreased survival, degeneration, and
loss of neurons in the brains of these mice. Furthermore,
MANF has been shown to be expressed in a portion of the
TH-positive neurons in the SNpc (Lindholm et al., 2008)
and therefore could affect their maintenance. To investi-
gate the role of MANF as a physiological trophic factor for
midbrain dopamine neurons, we analyzed the number of
surviving nigrostriatal dopamine neurons of mice lacking en-
dogenous MANF in the brain. Dopamine neurons in the
SNpc were visualized by immunoreactivity to TH, a rate-lim-
iting enzyme in dopamine synthesis. Relative quantification
of TH-stained neurons in the SNpc showed no loss of
continued
Figure 2. Upregulation of UPR genes in the brains of both conventional and conditional MANF KO mice. A, qPCR analysis of UPR
genes in the brains of E13.5 embryos and P1 and P14 pups of Manf-/- and Manf1/1 mice (n=5–9). B, qPCR analysis of UPR markers
in specific brain regions of five-week-old Manf-/- and Manf1/1 female mice (n=3–6). C, qPCR analysis detecting changes of UPR
markers in different brain parts of two-month-old Manffl/fl::NestinCre/1 female mice and Manffl/fl female littermates (n=4–9). D,
Representative Western blottings of brain homogenates comparing protein levels of GRP78, p-eIF2a, eIF2a, and GAPDH between
Manffl/fl::NestinCre/1 and Manffl/fl male mice. Optical density-based quantitation of protein levels in immunoblots, where GRP78 is nor-
malized to GAPDH (E), p-eIF2a to eIF2a (F), and eIF2a to GAPDH (G; n=4–6). H, mRNA levels of Bcl10 and Txnip in the cortex and
SN of two-month-old Manffl/fl::NestinCre/1 and Manffl/fl female mice (n=4–8). Results are scaled to the average value of the control
samples. Mann–Whitney U test or Student’s t test was used for statistical analysis. Data are expressed as mean 6 SEM.
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dopamine neurons in one-year-old Manffl/fl::NestinCre/1
mice (Fig. 4A; Table 1). The axonal branches and striatal ter-
minals of nigral neurons were detected by immunostaining
of striatal sections with antibodies detecting TH and dopa-
mine transporter (DAT; Fig. 4B). Optical densities of TH-posi-
tive and DAT-positive staining in the dorsal striatum were not
altered, indicating no detectable changes in the striatal inner-
vation of nigral dopamine neurons in one-year-old Manffl/fl::
NestinCre/1 mice (Fig. 4C; Table 1). Moreover, we stained
coronal brain sections including cortex and striatum with a
neuronal NeuN antibody, but no obvious changes in the
structure or number of positive cells were observed between
one-year-oldManffl/fl::NestinCre/1 andManffl/flmice (Fig. 4D).
In addition to morphology, striatal monoamine levels were
measured to examine possible changes in the activity of
dopamine neurons. The levels of dopamine and its
metabolites, DOPAC and HVA, were measured from the
striatal samples of 16-month-old mice by HPLC, i.e., at the
time when all three UPR pathways are activated in MANF-
deficient mice. The results showed no differences in the pro-
duction of dopamine or its metabolites betweenManffl/fl and
Manffl/fl::NestinCre/1 mice (Fig. 4E; Table 1). Unexpectedly,
NestinCre/1 mice had significantly elevated dopamine levels
when compared with Manffl/fl::NestinCre/1 mice, but there
were no differences in the levels of DOPAC or HVA.
Moreover, the levels of serotonin (5-hydroxytryptamine) and
its metabolite 5-hydroxyindoleacetic acid were measured,
and as a result, no differences were observed between the
groups (Fig. 4E; Table 1).
To assess possible changes in TH and DAT levels, we
studied their expression at mRNA and protein levels. The
mRNA levels of Th and Dat in the striatum and levels of Th
Figure 3. UPR remains activated in the brains of conditional MANF KO mice during aging. A, qPCR analysis of UPR gene expres-
sion in the cortex samples of 16-month-old Manffl/fl::NestinCre/1, Manffl/fl, and NestinCre/1 male mice (n=5–6). B, Similar analysis of
the SN from 16-month-old male mice (n=4–5). C, mRNA levels of Bcl10 and Txnip measured from the SN of 16-month-old Manffl/fl::
NestinCre/1, Manffl/fl, and NestinCre/1 male mice (n=4–6). D, Co-localization of TH and GRP78 in the SN of Manffl/fl::NestinCre/1 and
Manffl/fl female mice. Scale bar: 50mm. Results are scaled to the average value of the control samples. One-way ANOVA followed
by Tukey’s post hoc test was used for statistical analysis. Data are expressed as mean 6 SEM; pp Manffl/fl versus Manffl/fl::
NestinCre/1, and #p NestinCre/1 versus Manffl/fl::NestinCre/1.
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in the SN were analyzed by qPCR and the results showed
no differences in the level of their expression between
two-month-old Manffl/fl and Manffl/fl::NestinCre/1 mice
(Extended Data Fig. 4-1A; Extended Data Table 1-1).
Additionally, Western blot analysis indicated no changes
in the protein levels of TH and DAT in the striatum or TH
protein levels in the SN in Manffl/fl::NestinCre/1 mice com-
pared with control Manffl/fl mice (Extended Data Fig. 4-
1B,C; Extended Data Table 1-1). Thus, MANF deficiency
does not affect the expression of TH or DAT in the mid-
brain of young adult mice.
Mice lacking MANF in the brain exhibit normal motor
behavior
To investigate the effect of MANF absence from the
nervous system on functional level, we characterized
behavior ofManffl/fl::NestinCre/1mice using a battery of dif-
ferent behavioral tests. The nigrostriatal pathway controls
the initiation of movements and the cerebellum is important
for the coordination of movements. Therefore, we analyzed
motor behavior of MANF-deficient mice. Although the
NestinCre/1 line has been reported to have unaltered motor
behavior, learning and memory, we still used this mouse
line as a control, with Manffl/fl littermate controls for Manffl/fl::
NestinCre/1 mice (Giusti et al., 2014). Mice were tested at the
age of fourmonths andmost tests were repeated in the same
mice at the age of oneyear.
The performance in the multiple static rod test measuring
balance was similar between four-month-old Manffl/fl,
Manffl/fl::NestinCre/1 and NestinCre/1 mice (Fig. 5A; Table
1). In the wire hanger test, all mice had a similar latency to
fall, suggesting unaltered motor strength (Fig. 5B; Table 1).
Figure 4. Loss of MANF in the brain does not cause degeneration of nigrostriatal dopamine neurons in vivo. A, Representative pic-
tures of TH-stained coronal sections of the SNpc and quantification of dopamine neurons per section of the SNpc from one-year-
old Manffl/fl and Manffl/fl::NestinCre/1 female mice (n=5). Scale bar: 500 mm. B, Representative figures of TH-immunoreactivity and
DAT-immunoreactivity in coronal striatal sections. Scale bar: 2 mm. C, Measurement of optical density of TH-positive and DAT-pos-
itive dopamine fibers in one-year-old Manffl/fl::NestinCre/1 female mice and their Manffl/fl littermate controls (n= 5). D, Representative
NeuN-immunostaining in the sections from one-year-old Manffl/fl and Manffl/fl::NestinCre/1 female mice. Scale bar: 2 mm. E, HPLC
analysis of monoamine metabolites measured from striatal samples of 16-month-old male mice (n=6–8). DA, dopamine; DOPAC,
3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptamine. For statis-
tical analysis, the Student’s t test and Kruskal–Wallis test followed by Mann–Whitney U test were used. Data are presented as mean 6
SEM. See Extended Data Figure 4–1 for the further measurement of TH and DAT mRNA and protein levels in the striatum and SN.
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Figure 5. Lack of MANF causes no alterations in motor behavior, response to amphetamine, or learning and memory. A, Multiple
static rod test showing time to turn, time to walk 60 cm, and latency to fall using rods of different thickness from thicker (1) to thinner
(5) in four-month-old Manffl/fl (n=10), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=11) mice. B, In the wire hanger test, latency to
fall was measured in four-month-old Manffl/fl (n=10), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=11) mice. Latency to fall in an
accelerating rotarod test in four-month-old Manffl/fl (n=10), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=12) mice (C) and in one-
year-old Manffl/fl (n=9), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=10) mice (D). Spontaneous locomotor activity in an open-
field arena monitored for 30min in four-month-old Manffl/fl (n=10), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=12) mice (E) and
one-year-old Manffl/fl (n=8), NestinCre/1 (n=5), and Manffl/fl::NestinCre/1 (n=9) mice (F). Hyperactivity response following ampheta-
mine administration (3mg/kg, i.p.) after habituation in four-month-old Manffl/fl (n=10), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1
(n=11) mice (G) and in 14-month-old Manffl/fl (n=9), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=9) mice (H). The arrow points
out the time of amphetamine injection. I, In the Barnes maze test, mice were subjected to nine training sessions prior to the first
probe trial and six reverse training sessions before the second probe trial. Latency to find the target zone over training sessions is
presented for four-month-old Manffl/fl (n=10), NestinCre/1 (n=6), and Manffl/fl::NestinCre/1 (n=11) mice. J, Time spent around the tar-
get hole zone is presented for the first and second probe trials of the Barnes maze test. All the mice used in the behavioral test
were male mice. For statistical analysis, Kruskal–Wallis test, one-way ANOVA, and two-way repeated measures ANOVA followed by
Tukey’s post hoc test were used; pp Manffl/fl versus Manffl/fl::NestinCre/1. Data are presented as mean 6 SEM.
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Furthermore, the accelerated rotarod test measuring motor
learning and coordination showed no alterations in the be-
havior of four-month-old (Fig. 5C; Table 1) or 12-month-old
Manffl/fl::NestinCre/1 (Fig. 5D; Table 1) mice. To study the
general locomotor activity, mice were placed in an open
field and their activity monitored for 30min. As Figure 5E il-
lustrates, four-month-old Manffl/fl::NestinCre/1 mice moved
less than NestinCre/1 mice, but there was no difference in
activity compared with Manffl/fl littermates (Table 1). Fur-
thermore, there were no changes in the locomotor activity
between 12-month-old mice either (Fig. 5F; Table 1).
The functionality of the dopamine system in Manffl/fl::
NestinCre/1mice was analyzed by their responses to a do-
paminergic stimulant. Amphetamine releases dopamine
from vesicles in dopamine neurons and elevates striatal ex-
tracellular dopamine levels causing hyperactivity in mice
(Yates et al., 2007). The response to D-amphetamine meas-
ured by locomotor activity was similar between Manffl/fl::
NestinCre/1 and control mice at the age of four months (Fig.
5G; Table 1) and 14months (Fig. 5H; Table 1), although the
response to amphetamine was in general more modest in
older mice. These results suggest that both dopamine up-
take and release in the MANF-deficient striatum are normal.
Long-term memory formation relies on the synthesis of
new mRNA and proteins, but in the case of ER stress, and
particularly PERK pathway activation, protein translation
is attenuated (Ohno, 2018). Indeed, hippocampal ER
stress has been demonstrated to cause memory dysfunc-
tion (Zhang et al., 2014). Since we observed increased
UPR activation in Manffl/fl::NestinCre/1 mice, we decided
to investigate their spatial long-term memory by using the
Barnes maze test, which consists of training trials and
probe test trials measuring learning and long-term memo-
ry, respectively. In the second part of the test, the mice
are trained to find the new location of the escape box to
test behavioral flexibility. The results showed that four-
month-old mice had a similar learning pattern independ-
ent of the genotype (Fig. 5I; Table 1) and we could not see
differences between mice at one year of age either, indi-
cating no alteration in learning (data not shown). In the
memory test, the time spent in the target hole zone repre-
sents spatial long-term memory. The first and second
probe trials for four-month-old mice showed that Manffl/fl,
Manffl/fl::NestinCre/1, and NestinCre/1 mice spent a similar
amount of time in the target hole zone (Fig. 5J; Table 1)
and similar behavior was observed for one-year-old mice
(data not shown). Furthermore, there were no differences
between genotype groups in any other of the parameters
tested, which were latency to find the target hole zone,
number of visits in the target hole zone, and errors made
finding the target hole zone (data not shown). Thus, we
found no defects in learning and long-term memory of
Manffl/fl::NestinCre/1mice.
Cultured cortical neurons from embryonic MANF KO
mice show increased ER stress and vulnerability to
chemically-induced ER stress
To study the survival of MANF KO neurons in vitro, we
isolated dopamine neurons from the midbrain floor of
E13.5 Manf1/1 and Manf-/- embryos and cultured them
for 5 d. The number of surviving TH-positive cells was
measured by comparing the initial number of cells on
DIV1 with the number of cells on day 5. The results
showed no changes in the survival of non-treated TH-
positive neurons from MANF KO mice compared with
wild-type controls in vitro (Fig. 6A; Table 1).
Because of the scarce material obtained from a mid-
brain floor of one embryonic mouse, we could not plan
controlled chemical treatments and biochemical analysis
for MANF KO dopamine neurons. Therefore, we contin-
ued to study UPR activation in vitro using primary cortical
neurons isolated from Manf1/1, Manf1/-, and Manf-/- em-
bryos at day E16 or E17 as they can be easily obtained
with large quantities from embryonic mice. First, we eval-
uated the ER stress levels of cortical neurons cultured for
twoweeks. The cultures consisted mostly of a heterogen-
ic population of cortical neurons as they were treated with
mitotic inhibitors to reduce non-neuronal cell proliferation.
Increased UPR activation was found in Manf-/- cortical
neurons when compared with neurons from bothManf1/1
and Manf1/- embryos. Similarly to increased expression
of UPR genes in the brain of Manf-/- embryos in vivo (Fig.
2A), expression of Grp78, sXbp1, and tXbp1, but not
Chop and Atf6a, was increased in Manf-/- neurons cul-
tured for 14d in vitro (Fig. 6B; Table 1). In addition, the
mRNA levels of Atf4 were increased, suggesting activa-
tion of the PERK pathway. The Bcl10mRNA levels did not
differ between genotypes (Fig. 6B; Table 1).
The vulnerability of Manf-/- cortical neurons was as-
sessed by applying a chemical ER stressor, thapsigargin,
to the cultures. Thapsigargin blocks the sarcoendoplas-
mic reticulum calcium transport ATPase (SERCA) pump
and depletes Ca21 stores from the ER, leading to UPR ac-
tivation and cell death in various cell types, including neu-
rons (Li and Hu, 2015). Thapsigargin at a concentration of
10 nM for 48 h led to a 66.36 10.4% reduction in Manf-/-
neuronal survival compared with dimethyl sulfoxide
(DMSO)-treated neurons, whereas the decrease in sur-
vival of control Manf1/1 neurons was 34.96 7.9% and
Manf1/- neurons 37.16 13.4% (genotype–treatment inter-
action, p=0.039; Fig. 6C; Table 1). At 5 nM thapsigargin,
no changes in the number of surviving neurons were de-
tected (Fig. 6C). As a result, neurons without endogenous
MANF were more vulnerable to thapsigargin-induced ER
stress in vitro.
To examine further the effect of thapsigargin on neuro-
nal cultures, the expression of several UPR markers was
analyzed after a 48-h-long exposure to 10 nM thapsigar-
gin. Upregulation of many UPR genes, Atf6a, Atf4, Chop,
Grp78, sXbp1, and tXbp1, was detected after thapsigar-
gin treatment in all genotypes (Fig. 6D–I; Table 1).
Furthermore, expression of Bcl10was higher in thapsigar-
gin-treated neurons compared with DMSO-treated ones
(Fig. 6J; Table 1). The treatment with 10 nM thapsigargin
resulted in a significant genotype–treatment interaction
only regarding mRNA levels of sXbp1 (p=0.012; Table 1).
Thus, the results showed higher upregulation of sXbp1 in
Manf-/- neurons compared withManf1/1 andManf1/- neu-
rons (Fig. 6H). We also measured the mRNA levels of
Txnip in the samples, and the levels were upregulated in
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response to thapsigargin but did not differ between the
genotypes (Fig. 6K; Table 1).
Finally, as sustained ER stress is known to induce
NF-kB activation by IRE1a activation (Kaneko et al.,
2003), we also evaluated the phosphorylation of NF-kB
by Western blotting (Fig. 6L). Because of a small sample
size, we combined Manf1/1 and Manf1/- samples to-
gether. Quantification of intensity in Western blotting
bands showed only a trend towards increased phospho-
rylation of NF-kB in Manf-/- neurons after 10 nM
Figure 6. ER stress in embryonic cortical cultures of Manf-/- mice and their vulnerability to thapsigargin (TG). A, Survival of embry-
onic midbrain dopamine neurons in vitro isolated from Manf1/1 and Manf-/- mice (n=7–8). B, Expression of UPR related and Bcl10
genes in Manf1/1, Manf1/-, and Manf-/- cortical neurons cultured for 14d and studied by qPCR (n=4–8). C, Effect of the TG treat-
ment on neuronal survival. Cortical neurons were treated with TG at DIV9, fixed after 48 h, and stained with the NeuN antibody
(n=3–5). The loss of cells was quantified by comparing the neuron number with vehicle-treated cultures. Neurons were similarly
treated with TG at DIV9, collected after 48 h and analyzed by qPCR for the expression of Aft6a (D), Atf4 (E), Chop (F), Grp78 (G),
sXbp1 (H), tXbp1 (I), Bcl10 (J), and Txnip (K) expression (n=3–5). L, Western blottings presenting phosphorylated NF-kB and NF-
kB expression in Manf1/1, Manf1/-, and Manf-/- cortical cultures after 48-h-long exposure to TG. M, Quantification of Western blot-
tings, where p-NF-kB is normalized to NF-kB (n=4–5). Results are scaled to the average value of the control samples. Each data
point represents one animal and its value is an average of at least two wells. Data are expressed as mean 6 SEM of at least three
independent experiments. Experimental groups were compared by the Student’s t test, one-way ANOVA, or two-way ANOVA fol-
lowed by Tukey’s multiple comparison test.
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thapsigargin treatment compared with that in control neu-
rons (Fig. 6M; Table 1).
Discussion
In this study, we elucidate the previously unknown func-
tion of endogenous MANF in the mouse brain. Previous
studies have suggested a function for MANF in the mainte-
nance of neurons based on neuroprotective and neurores-
torative effects of MANF in different rodent degenerative
disease models (Airavaara et al., 2009; Voutilainen et al.,
2009; Yang et al., 2014; Neves et al., 2016). However, our
results indicate for the first time that endogenous MANF is
not needed for the maintenance of midbrain dopamine
neurons in mice. It has been implicated, that accumulation
of misfolded or aggregated proteins followed by severe
chronic UPR causes neuronal death in neurodegenerative
diseases. This study, however, questions this present view
and shows that sustained but moderate UPR in the rodent
brain is not detrimental.
The phenotype of conventional Manf-/- is dominated by
the development of insulin-dependent diabetes, a severe
growth defect and premature death (Lindahl et al., 2014).
On the contrary, Manffl/fl::NestinCre/1 mice are viable and
have a normal lifespan without diabetes or gross defects,
but adult Manffl/fl::NestinCre/1 mice have a decreased
body weight when compared with littermate Manffl/fl con-
trols. In a recent study, Manf knock-down by siRNA from
the hypothalamus resulted in hypophagia and reduced
body weight (Yang et al., 2017), suggesting that Manffl/fl::
NestinCre/1 mice could be smaller due to hypophagia.
However, NestinCre/1 mice themselves have been re-
ported with a growth defect due to reduced levels of
mouse growth hormone (Galichet et al., 2010; Declercq et
al., 2015). Therefore, the reduced weight in Manffl/fl::
NestinCre/1 mice is affected by the NestinCre/1 transgene
and the effect of hypothalamic MANF deficiency on food
intake requires more investigations.
Upon ER stress, the IRE1a receptor is autophosphory-
lated and its RNase activity leads to degradation of
mRNAs and unconventional splicing of Xbp1 mRNA
(Walter and Ron, 2011). Our study reveals increased acti-
vation of the IRE1a RNase pathway in the brains of both
conventional Manf-/- mice and conditional Manffl/fl::
NestinCre/1mice. In young adultManf-/-mice, UPR activa-
tion seems more severe with increased expression of
ChopmRNA, which may be partially due to the manifesta-
tion of hyperglycemia as cerebral ER stress has been re-
ported in diabetic mice (Zhao et al., 2015). Spliced XBP1
induces the expression of UPR target genes, such as
Grp78 (Hetz and Saxena, 2017). Indeed, Grp78 expres-
sion is also increased in tissue samples where splicing of
Xbp1 is elevated. The increased phosphorylation of eIF2a
in the brains of Manffl/fl::NestinCre/1 mice does not result
in increased expression of its downstream components
Atf4 nor Chop indicating only minor PERK pathway acti-
vation at young age. However, in 16-month-old Manffl/fl::
NestinCre/1 mice, expression of Atf4 and Atf6a are in-
creased suggesting activation of both PERK and ATF6
pathways in the brain at older age. Interestingly, the IRE1a
RNase pathway is chronically stimulated through the
lifespan of Manffl/fl::NestinCre/1 mice. Therefore, supporting
previous findings in other tissues (Wang et al., 2018;
Hartman et al., 2019), we conclude that also in neurons
MANF regulates UPRmainly through the IRE1a pathway.
In rats, exogenously added and striatally overexpressed
MANF protects dopamine neurons in the 6-hydroxydopa-
mine model of Parkinson’s disease (Voutilainen et al.,
2009; Hao et al., 2017). Here, we analyzed whether MANF
deficiency and chronic UPR in the mouse brain leads to
nigrostriatal neurodegeneration. It has been shown that in
Parkinson’s disease dopamine neurons start to degener-
ate by losing their synapses and axons. This is observed
both in patients and in Parkinson’s rodent disease models
with clear Parkinson’s disease phenotype (Domanskyi et
al., 2015). In this study, we measured the optical density
of striatal dopamine fibers by two different markers, TH
and DAT, and did not observe any differences in density
between the genotypes. We also used even more sensi-
tive measurements for dopamine neuronal degeneration
by quantifying striatal dopamine concentrations and its
metabolite levels with HPLC, and did not find any differen-
ces between the genotypes. The concentrations of the
striatal samples were in range of 7.6–25.4mg/g of tissue,
and similar that we have published before (Albert et al.,
2019). Based on these results, maintenance of dopamine
neurons is not affected by the embryonic onset of MANF
deficiency in the mouse brain, which supports another
study showing MANF not being a crucial survival factor for
dopamine neurons in Caenorhabditis elegans (Hartman et
al., 2019).
Synaptic alteration and loss occur at early stages of neu-
rodegenerative diseases, such as Alzheimer’s, Parkinson¨s
and Lewy body diseases (Hunn et al., 2015; Overk and
Masliah, 2014). It has been demonstrated in mice that syn-
apses can degenerate, although striatal dopamine fibers
and dopamine levels stay unchanged (Galli et al., 2014).
Therefore, in the future, it will be important to quantify the
number of synapses (DeKosky and Scheff, 1990) and ex-
amine individual synapses of dopamine neurons in MANF-
deficient mice using highly sensitive technologies, such as
mass synaptometry (Gajera et al., 2019). Furthermore,
changes in dopamine transmission at the synapses can
also occur without dopamine neuron loss as shown in
CDNF KO mice (Lindahl et al., 2020). Despite the un-
changed response to amphetamine, detailed investigation
of the dopamine neurotransmission in MANF-deficient
mice would be justified in the future.
It is possible that embryonic deletion of MANF is com-
pensated by factors that remain unknown. We confirmed
that at least in the adult brain, loss of MANF is not com-
pensated by its protein family member CDNF, but future
studies on CDNF-MANF double KO mice are relevant.
With possible functional compensation in mind, we also
quantified the mRNA levels of Bdnf, Th, and Dat and pro-
tein levels of TH and DAT but found no changes in their
levels between the genotypes. In future studies it will be
important to eliminate embryonic compensatory effects in
the MANF KO mice by deleting MANF specifically from
the brain in adult mice. It has been shown that in ischemic
brains, MANF is expressed in activated microglia (Shen et
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al., 2012). Other studies also demonstrate expression of
MANF by myeloid cells (Neves et al., 2016; Mätlik et al.,
2018). It is possible that MANF is expressed by microglia
in ourManffl/fl::NestinCre/1 mice. However, we did not find
detectable levels of Manf mRNA expression in the cortex
of 16-month-old Manffl/fl::NestinCre/1 mice suggesting no
microglial upregulation of MANF.
Normal locomotor activity of Manffl/fl::NestinCre/1 mice
is in line with unaltered open field activity of Manf-/- mice
(Lindahl et al., 2014). In NestinCre/1 mice, slightly higher
locomotor activity could be explained by their surprisingly
higher striatal dopamine levels. However, this phenomen-
on might be due to differences in a genetic background
as our breeding did not generate NestinCre/1 littermate
control mice alone. Although ER stress can impair long-
term memory (Ohno, 2018), hippocampal sXBP1 overex-
pression, instead, has been shown to improve long-term
memory through elevated Bdnf levels (Martínez et al.,
2016). However, we did not observe changes in the hip-
pocampal Bdnf mRNA levels in Manffl/fl::NestinCre/1 mice
possibly explaining the unchanged memory consolida-
tion. Thus, despite increased expression of Grp78 and
sXbp1 mRNA in the hippocampus of Manffl/fl::NestinCre/1
mice, behavioral tests showed that MANF deficiency
does not result in memory impairment.
We have shown that exogenously administered MANF
before cerebral ischemia protects cortical neurons in rats
(Airavaara et al., 2009) and poststroke delivery of MANF
induces functional recovery of rats after cerebral ischemia
(Mätlik et al., 2018). Moreover, the infarction size in the
MANF-deficient brain is larger, indicating that endogenous
MANF has a protective effect on cortical neurons against
ischemic injury (Mätlik et al., 2018). Therefore, we exam-
ined ER stress in the Manf-/- primary cortical neurons.
Cortical MANF KO neurons show increased ER stress
levels, confirming that the increased UPR activation is
neuronal. We also report decreased survival of thapsigar-
gin-treated MANF-depleted cortical neurons, suggesting
increased vulnerability of Manf-/- cortical neurons in vitro.
Neurons in cortical cultures were quantified based on their
immunoreactivity to NeuN, although we acknowledge the
issues related to its use in primary cultures. It has been
criticized that also astrocytes can show immunoreactivity
to NeuN in vitro (Darlington et al., 2008) and that the loss of
NeuN expression does not necessarily correlate with cell
death (Unal-Cevik et al., 2004). Here, we used it as a
marker for the vulnerability of neurons to chemically-in-
duced ER stress comparing with untreated neurons.
Previously, we reported impairments in the cortical de-
velopment of Manf-/- brain, but the adult cortex is mor-
phologically normal (Tseng et al., 2017). Our results here
show increased UPR activation in the brain of Manf-/-
mice during embryonic and postnatal development, but
activation seems to gradually decrease after birth. UPR
has been shown to be tightly regulated during neurode-
velopment and to play a critical role during maturation of
neurons and in neurodevelopmental diseases (Laguesse
et al., 2015; Godin et al., 2016; Gladwyn-Ng et al., 2018).
Interestingly, a patient with a homozygous missense mu-
tation in the MANF gene likely leading to a null mutation
was presented with microcephaly and diabetes (Yavarna
et al., 2015). Thus, the impact of MANF in the develop-
ment of the human brain might differ compared with mice.
Whereas chronic UPR activation kills b cells (Lindahl et
al., 2014), neuronal loss is not observed in the midbrain of
Manffl/fl::NestinCre/1 mice. One of the actors determining
the switch between adaptive and terminal UPR followed
by IRE1a activation is TXNIP (Anthony and Wek, 2012).
However, in Manffl/fl::NestinCre/1 mice midbrain the IRE1a
pathway is activated without increased expression of
Txnip mRNA. One of the differences between b cells and
dopamine neurons is that b cells produce and secrete in-
sulin at a high rate, making them vulnerable to additional
ER perturbation. Although chronic ER stress in b cells
leads to increased activation of the NF-kB pathway
(Danilova et al., 2019a), this pathway is not upregulated in
neuronal tissue lacking MANF. As expression of Bcl10
mRNA or phosphorylation of NF-kB was not differently
regulated between genotypes after thapsigargin adminis-
tration, we suggest that the increased susceptibility of
MANF KO neurons to thapsigargin is not related to the ac-
tivation of the NF-kB pathway. We conclude that the
IRE1a-TRAF2-NF-kB branch is not activated in MANF-
deficient neurons.
A recent study suggests that MANF functions as a nega-
tive regulator of IRE1 and XBP1 activity in nematodes
(Hartman et al., 2019). Our data demonstrating how abla-
tion of Manf increases sXbp1 levels agrees with this hy-
pothesis. The IRE1a–XBP1 pathway is regarded as an
UPR branch, which can, differently from others, also en-
hance cell viability (Lin et al., 2009). Activation of this path-
way has also demonstrated neuroprotection in different in
vivomodels of CNS diseases (Ni et al., 2018). In the MPTP-
induced animal model of Parkinson’s disease, for example,
expression of sXBP1 protects dopamine neurons (Sado et
al., 2009). We can hypothesize that in our mouse model,
neurons are adapted to constant, non-pathologic activa-
tion of the IRE1a pathway increasing the capability to sur-
vive from the terminal UPR. Developmental deletion of
XBP1 in the nervous system also causes ER stress in the
mouse brain, which protects dopamine neurons, whereas
reduction of XBP1 levels at the adult stage results in neuro-
degeneration (Valdés et al., 2014). The authors speculate
that developmental adaptation to ER stress would explain
the protection of dopamine neurons (Valdés et al., 2014). A
similar adaptation might occur in our Manffl/fl::NestinCre/1
mice, and therefore, adult knock-down ofManf expression
may lead to a deleterious outcome.
In conclusion, our study describes a mouse model with
prolonged UPR activation in the brain. We discovered a
different effect of sustained ER stress between neurons
and b cells. Whereas terminal UPR kills b cells in the
Manf-/- pancreas, there is no neurodegeneration in the
midbrain dopamine system of Manffl/fl::NestinCre/1 mice
despite the upregulation of UPR genes. However, the lack
of MANF decreases survival of cultured cortical neurons
when exposed to chemically-induced ER stress. This is
the first study analyzing the role of endogenous MANF in
the nigrostriatal dopamine system with the conclusion
that in our transgenic mouse model, MANF expression
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does not seem to be needed for the proper function of
midbrain dopamine neurons in the aging brain.
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